
Scripps Florida and Mayo Clinic Team Up to Successfully Target Common Mutation in Lou Gehrig's Disease and Frontotemporal Dementia JUPITER, FL, August 14, 2014 An international team led by scientists from the Florida campuses of The Scripps Research Institute (TSRI) and the Mayo Clinic have for the first time successfully designed a therapeutic strategy targeting a specific genetic mutation that causes a common form of amyotrophic lateral sclerosis (ALS), better known as Lou Gehrig's disease, as well a type of frontotemporal dementia (FTD).
The scientists developed small-molecule drug candidates and showed they interfere with the synthesis of an abnormal protein that plays a key role in causing both diseases. The team also developed biomarkers that can test the efficacy of this and other therapies.
The study, led by Professor Matthew Disney of TSRI and Professor of Neuroscience Leonard Petrucelli of the Mayo Clinic, was published online ahead of print August 14, 2014 in the journal Neuron.
Our small molecules target a genetic defect that is by far the most major cause of familial ALS, and if you have this defect you are assured of getting ALS or FTD, Disney said. Our findings show for the first time that targeting this mutation with a small-molecule drug candidate can inhibit toxic protein translation and establishes that it could be possible to treat a large number of these patients, but this is just the start of these studies and additional investigations need to be done.
Currently, ALS is usually fatal two to five years after diagnosis, and there is no effective treatment for FTD, a neurodegenerative disease that destroys neurons in the frontal lobes of the brain.
Toxic Buildup
The mutation that can cause both diseases affects a gene known as C90RF72 and involves a repeat expansion, a longer than usual repetitive genetic sequence. This results in abnormal strands of RNA and the production of toxic c9RAN proteins.
Disney and his Scripps Florida colleagues initially designed three small-molecule drug candidates that decreased RNA translation or production of these toxic proteins in cell culture. The Mayo team developed the patient-derived cell models in which to test the compounds and the biomarker to assess compound activity. Both teams then worked together to show that the lead agent's mode of action was targeting the toxic RNA, binding to and blocking the toxic RNA's ability to interact with other key proteins.
Two of the compounds significantly decreased levels of the toxic protein. Using a series of increasing dosages of the drug candidates, the scientists found that the highest dosage of one reduced the toxic protein by nearly 50 percent.
The scientists also discovered that c9RAN proteins produced by the abnormal RNA can be measured in the spinal fluid of ALS patients. They are now evaluating whether these proteins are also present in spinal fluid of patients diagnosed with FTD.
A decrease in the levels of toxic proteins in cerebrospinal fluid in response to treatment would demonstrate the drug is working, Petrucelli said. While additional studies must be done, this finding suggests that these proteins may provide a direct means to measure a patient's response to experimental drugs that target abnormal RNA.
Toxic proteins found in spinal fluid could also become an enrollment tool in human clinical trials, added Disney, who was enthusiastic about the collaboration with the Mayo Clinic and the larger team. Our collective biological and chemical expertise made this research possible, he said. This is just the beginning of what we can do together.
The first authors of the study, Discovery of a Biomarker and Lead Small Molecules to Target r(GGGGCC)-Associated Defects in c9FTD/ALS, are Zhaoming Su of TSRI and Yongjie Zhang, Tania F. Gendron and Peter O. Bauer of the Mayo Clinic.
Other authors include Wang-Yong Yang and Erik Fostvedt of TSRI; Jeannie Chew, Karen Jansen-West, Veronique V. Belzil, Pamela Desaro, Amelia Johnston, Karen Overstreet, Bradley F. Boeve, Dennis Dickson, Rosa Rademakers and Kevin B. Boylan of the Mayo Clinic; Mary Kay Floeter of the National Institute of Neurological Disorders and Stroke; Bryan J. Traynor of the National Institute on Aging; Claudia Morelli of the IRCCS Instituto Auxologico Italiano, Milan, Italy; Antonia Ratti and Vincenzo Silani of the IRCCS Instituto Auxologico Italiano, Milan, Italy and the Universita degli Studi di Milano, Milan, Italy; and Robert H. Brown and Jeffrey D. Rothstein of Johns Hopkins University.
The work was supported the National Institute on Aging of the National Institutes of Health (grants R01GM097455, R01AG026251 and P50AG016574); National Institute of Neurological Disorders and Stroke (grants R21NS074121, R21NS079807, R21NS084528, R01NS088689, R01NS063964, R01NS077402 and R01NS050557); the American Recovery and Reinvestment Act of 2009 (awards RC2-NS070-342 and P01NS084974); National Institute of Environmental Health Services (grant R01ES20395); Department of Defense (ALSRP AL130125); Mayo Clinic Foundation; Mayo Clinic Center for Regenerative Medicine; Mayo Clinic Center for Individualized Medicine; ALS Association; Alzheimers Association; Robert Packard Center for ALS Research at Johns Hopkins; Target ALS; Project ALS; Angel Fund; the Italian Ministry of Health (RF-2009-1473856) and the European Commission.
About The Scripps Research Institute
The Scripps Research Institute (TSRI) is one of the worlds largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founde
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
20/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
20/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
20/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
20/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
20/11/2026
Beam Dynamics has introduced new Model Context Protocol (MCP) support, expanding how customers can work with the live operational data held in Beam. The new cap...
20/11/2026
Re:Vision Effects Cyber Week Sale Nov 24 to Nov 30
Pierre Jasmin November 19, 2026
0 Comments
Long time friends of the COW are up with a big sale!
Us...
20/11/2026
Avid is offering up to 33% off annual subscriptions!
Brie Clayton November 19, 2026
0 Comments
Hero image courtesy Deposit Photos
Pro Tools
Pro To...
19/11/2026
With a sports-bar vibe and all the teams onsite in a huge atrium in Ballpark Vil...
19/11/2026
The senior from Phoenix and England is balancing life as a Division I tennis player with a growing career behind the microphone
The future of live sports produ...
19/11/2026
RED Digital Cinema and Colorfront have partnered to integrate native Colorfront color management into RED Connect, letting productions apply Colorfront's co...
19/11/2026
SMPTE has published an engineering report summarizing an industry survey by its Study Group on Content Provenance and Authenticity in Media. The findings point ...
19/11/2026
CTech and Skyline Communications have announced a partnership to deliver integra...
19/11/2026
Euskal Irrati Telebista (EITB), the Basque Country's public media group, has completed Phase 1 of a five-studio renewal with the commissioning of a Lawo IP ...
19/11/2026
The Esports Foundation (EF) has announced an expanded Road to ENC 2027 for the E...
19/11/2026
All Women's Sports Network (AWSN) held its first awards show, VEON: Women W...
19/11/2026
Gracenote, the content intelligence business unit of Nielsen, has extended its relationship with DIRECTV. Gracenote will continue to supply visual imagery and p...
19/11/2026
The Audio Engineering Society (AES) Technical Committee on Broadcast and Online ...
19/11/2026
NDI has released NDI 6.4, which adds Recording and Playback APIs, support for HEVC 4:4:4 and a configurable receiver buffer for Wi-Fi. The update also includes ...
19/11/2026
Lemonlight, the video production company behind more than 50,000 brand videos, has announced Hero, an AI production operating system, along with a new AI agent ...
19/11/2026
In a first-of-its-kind deployment at XFINITY Center, the digital signage/display...
19/11/2026
For the first time on a US streaming service, real-time player identification, contextual stats, and visual insights appear right in the live stream, available ...
19/11/2026
His career runs from the 2-in. videotape era to Canada's first HD and UHD live-production facilities...
19/11/2026
The popular sports-graphics event features a new Chairperson and new venue...
19/11/2026
Beth de Ara jo, Gemma Chan, Channing Tatum and Mason Reeves attend the premiere of Josephine at Eccles Theatre on January 23, 2026, in Park City, UT. (Photo b...
19/11/2026
New performance-focused brass library announced
Expressive E's latest release brings together four meticulously sampled brass instruments: sousaphone, b...
19/11/2026
Acoustic synthesizer gains free web editor
The phase8 acoustic synthesizer has been an ongoing project for Korg Berlin. It was unveiled as an early prototyp...
19/11/2026
MIDI controller keyboards upgraded
Designed for users who want a full-size keyboard and hands-on DAW control but in a relatively compact footprint, Nektar...
19/11/2026
Hugely popular compact monitor overhauled
IK Multimedia's ultra-compact monitors have proven to be incredibly popular, and the company say that they'...
19/11/2026
Rohde & Schwarz brings company-wide technology and service expertise to critical...
19/11/2026
On October 8, 2026, Nielsen employees came together around the world to celebrate our fourteenth company-wide day of service, Nielsen Global Impact Day (NGID). ...
19/11/2026
Integrating Gracenote's content intelligence with Nexxen's unique CTV supply allows advertisers to more closely align campaigns with audience viewing ha...
19/11/2026
Enhancement Mirrors Local TV's Recent Move to 1-Minute Qualifier (1MQ)
Upda...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , er...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
As Founder and Creative Director of Future Phonic Studios, the Netherlands' first Dolby Atmos music studio, Richard Burki has spent more than a decade pushi...
19/11/2026
Boris FX Black Friday Sale - 25% Off Everything
Brie Clayton November 19, 2026
0 Comments
Check out the Boris FX Black Friday sale on Monday, November...
19/11/2026
Virtual Production Finds Its Middle Ground with Blackmagic Design
Brie Clayton November 19, 2026
0 Comments
How Neon Vision is using PYXIS 12K and Ult...
19/11/2026
FL Studio Announces Black Friday Discounts of Up to 50% Across Its Software Line...
19/11/2026
TBS Drama Series Tagusari Brothers Uses DaVinci Resolve Studio
Brie Clayton November 19, 2026
0 Comments
TBS ACT streamlines post production for broad...
19/11/2026
Beeble launches SwitchX 3.0 with dynamic environments and greater creative contr...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , er...
19/11/2026
Five-year deployment has automated APL's media supply chain from fixture to archive, managing over 200,000 assets
Blue Lucy, the workflow orchestration and...
19/11/2026
Riding the Australian wave through co-pros 11 November 2026
L-R: The Surfer, We Bury the Dead
Australian stories are captivating global audiences and attracti...
19/11/2026
Screen Australia and Australian Film Television and Radio School announce the Fi...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...